Direct-Acting Oral Anticoagulants

Direct-Acting Oral Anticoagulants


Identification: MSNJ2022
Issue: November-December 2020
Volume: Vol. 29/No. 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2022
  • 1.30 - CH
  • 1.30 - Rx

Non-member: $20.00

Description

Contact hours available until 12/31/22.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.

Learning Outcome:
After completing this education activity, the learner will be able to initiate proactive measures and provide targeted patient education to prevent adverse events associated with these drugs.

Author(s)

Credits Available


Direct-Acting Oral Anticoagulants

You must be logged in and own this product in order to post comments.

Lisa Humiston
1/5/21 10:52 pm

Great article, direct and to the point, very informative.

Ana Riza Mckee
1/9/21 5:37 am

Very informative article.

Camille Morgan
1/11/21 12:45 am

Very good article, informative.

Barbara Potts
1/12/21 11:36 am

The information on the Factor Xa inhibitors is appreciated. This is the newest generation of anti-coagulants that we are using in the acute care setting.

Alketa Stephens
1/20/21 3:06 pm

It was a great article. Thank you!

Allison Weech
2/15/21 2:33 pm

I learned that the newer anticoagulants are much safer than Warfarin, however, more research is needed to determine how safe they are with continued long term usage.

Joanne Turner
4/28/21 11:00 am

Great article, eye opener. The problem remains, cost. It is a barrier with patients and no insurance.THANKS

Marta Paul
5/7/21 12:48 pm

I enjoyed reading this article as we are frequently giving oral anticoagulants to patients. Very good information!

Ivory Pedral
7/17/21 5:32 pm

Direct-acting oral anticoagulants are among the most common medications administered by clinical medical-surgical nurses. Proactive measures and targeted patient education should be encouraged to prevent adverse events associated with these drugs. Literature and treatment guidelines reviewed and discussed in this article will provide nurses with additional information on safe administration of DOACs

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
Number of hours attended:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content